{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T13:12:10Z","timestamp":1721913130664},"reference-count":15,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7825","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T07:05:02Z","timestamp":1564470302000},"source":"Crossref","is-referenced-by-count":2,"title":["Osteoporotic vertebral fracture caused by topical corticosteroid abuse: A case report"],"prefix":"10.3892","author":[{"given":"Stefano","family":"Piaserico","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Medicine, University of Padua, Padua I\u201135128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Linder","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Ben Gurion University of The Negev, Beer\u2011Sheva 84101, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Messina","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medicine, University of Padua, Padua I\u201135128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medicine, University of Padua, Padua I\u201135128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"key20200713100916_b1-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s12020-010-9393-6","article-title":"Exogenous Cushing's syndrome due to topical corticosteroid application: Case report and review of the literature","volume":"38","author":"Tempark","year":"2010","journal-title":"Endocrine"},{"key":"key20200713100916_b2-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3109\/09546634.2012.755252","article-title":"Iatrogenic Cushing's syndrome and topical steroid therapy: Case series and review of the literature","volume":"25","author":"Decani","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"key20200713100916_b3-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4274\/Jcrpe.726","article-title":"Iatrogenic Cushing's syndrome following short-term intranasal steroid use","volume":"4","author":"Dutta","year":"2012","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"key20200713100916_b4-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1523-1747.2003.12053.x","article-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: Inhibition of epidermal lipid synthesis accounts for functional abnormalities","volume":"120","author":"Kao","year":"2003","journal-title":"J Invest Dermatol"},{"key":"key20200713100916_b5-etm-0-0-7825","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2265.2003.18021.x","article-title":"Cushing's syndrome secondary to topical corticosteroids abuse","volume":"58","author":"Ermis","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20200713100916_b6-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0190-9622(98)70573-0","article-title":"Super potent topical corticosteroids use associated with adrenal suppression: Clinical consideration","volume":"38","author":"Gilbertson","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key20200713100916_b7-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/014107688708000709","article-title":"Adrenal suppression following low-dose opical clobetasol propionate","volume":"80","author":"Ohman","year":"1987","journal-title":"J R Soc Med"},{"key":"key20200713100916_b8-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-4362.1996.tb03647.x","article-title":"Erythrodermic psoriasis associated with hyperuricemia and iatrogenic Cushing's syndrome due to topical corticosteroid therapy","volume":"35","author":"Ohnishi","year":"1996","journal-title":"Int J Dermatol"},{"key":"key20200713100916_b9-etm-0-0-7825","doi-asserted-by":"crossref","first-page":"542","DOI":"10.5694\/j.1326-5377.1971.tb87696.x","article-title":"Temporary Cushing's syndrome from percutaneous absorption of betamethasone 17-valerate","volume":"1","author":"Keipert","year":"1971","journal-title":"Med J Aust"},{"key":"key20200713100916_b10-etm-0-0-7825","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1742-1241.1991.tb08832.x","article-title":"Unrecognised Cushing's syndrome and adrenal suppression due to topical clobetasol propionate","volume":"45","author":"Young","year":"1991","journal-title":"Br J Clin Pract"},{"key":"key20200713100916_b11-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/09546634.2014.933164","article-title":"A case of multiple bone fractures due to the use of topical corticosteroid therapy for psoriasis","volume":"26","author":"G\u00f6n\u00fcl","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"key20200713100916_b12-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-induced osteoporosis: An update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"key":"key20200713100916_b13-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.semarthrit.2014.05.008","article-title":"Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: A systematic review and meta-analysis","volume":"44","author":"Haroon","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"key20200713100916_b14-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00198-013-2548-6","article-title":"IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis","volume":"25","author":"Moln\u00e1r","year":"2014","journal-title":"Osteoporos Int"},{"key":"key20200713100916_b15-etm-0-0-7825","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bone.2018.01.027","article-title":"Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions","volume":"110","author":"Shukla","year":"2018","journal-title":"Bone"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T17:26:52Z","timestamp":1695058012000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":15,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7825","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]}}}